What is Coffin-Lowry Syndrome?
At a Glance
Coffin-Lowry Syndrome (CLS) is a rare genetic disorder caused by an RPS6KA3 gene mutation. It typically affects males more severely and causes intellectual disabilities, physical differences, and drop episodes. While there is no cure, symptoms can be managed with a proactive care team.
Receiving a diagnosis of Coffin-Lowry Syndrome (CLS) can feel like entering an unfamiliar world. It is a rare, multisystem genetic disorder, and the road to this discovery has likely been long and confusing. Validation of your experience is the first step toward management; because the physical signs of CLS are often subtle in infancy and become more distinct as a child grows, many parents face years of uncertainty before getting an answer [1][2].
This guide is designed to help you organize the care for your child, understand the unique medical and developmental aspects of the condition, and advocate for their long-term health. Below is a roadmap of the topics covered in this resource:
Managing Stimulus-Induced Drop Episodes (SIDEs)
Learn how to manage Stimulus-Induced Drop Episodes (SIDEs) in Coffin-Lowry syndrome. Understand triggers, safety strategies, and how SIDEs differ from seizures.
Long-Term Monitoring: Skeletal, Cardiac, and Dental Health
Learn the essential long-term monitoring checklist for Coffin-Lowry Syndrome (CLS). Understand skeletal, cardiac, respiratory, and dental screening guidelines.
Building Your Care Team & Surgical Precautions
Learn how to build a multidisciplinary care team for Coffin-Lowry Syndrome. Understand critical surgical precautions, anesthetic risks, and how to prepare.
Understanding the Diagnosis
CLS is caused by mutations in the RPS6KA3 gene, located on the X chromosome [3]. This gene is responsible for creating a protein (RSK2) that helps neurons communicate and helps cells grow [3]. In many cases, this is a de novo mutation, meaning it occurred spontaneously. However, in about 20-30% of cases, it is passed down from a mother who is a carrier (and who may have very mild or no symptoms due to X-inactivation) [4][5]. We strongly recommend genetic counseling for parents to understand recurrence risk for future pregnancies.
The syndrome is rare, estimated to affect approximately 1 in 40,000 to 50,000 individuals. Because it is an X-linked dominant condition, it typically affects males more severely, while females may have a wide range of symptoms—from very mild to more significant challenges [6][7].
Three Stabilizing Facts
In the wake of a new diagnosis, it is vital to ground yourself in the clinical realities of the condition:
- This is not your fault. Whether it occurred spontaneously or was passed down, this is a genetic event and not a result of your lifestyle or choices before or during pregnancy [4].
- Management is possible. While there is currently no cure, CLS is a manageable condition. A proactive, multidisciplinary care team can monitor and treat specific symptoms, such as skeletal changes or cardiac health, to improve your child’s physical quality of life [8][6].
- You are not alone. There is a community of families navigating this exact journey. Finding a rare disease patient advocacy group or a CLS-specific community is vital for emotional survival, practical daily tips, and ongoing support.
The Diagnostic Journey and Evolution
One of the most frustrating aspects of CLS is the “diagnostic odyssey.” In early childhood, the facial features associated with CLS—such as a prominent forehead, a wide mouth, or a depressed nasal bridge—may not be obvious [9][2]. These characteristics often become more “coarse” or prominent as the child ages. Because of this, many children are initially diagnosed with non-specific intellectual disabilities or speech delays before receiving genetic confirmation [9][10].
By securing this diagnosis, you have moved from the “unknown” to a place where you can begin to assemble a robust care team and implement early interventions. You can click on the sections above to continue reading and empower yourself for the journey ahead.
Common questions in this guide
What causes Coffin-Lowry Syndrome?
Why is Coffin-Lowry Syndrome hard to diagnose in infancy?
Are boys and girls affected differently by Coffin-Lowry Syndrome?
Should parents get genetic testing if their child has CLS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What are the most immediate next steps in our care plan, and who is the central doctor managing my child's case?
- 2.Can you refer us to a medical social worker or patient advocacy group to connect with other Coffin-Lowry families?
- 3.Should we consult a genetic counselor to discuss family planning and testing for maternal carrier status?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (10)
- 1
First female Korean child with Coffin-Lowry syndrome: a novel variant in RPS6KA3 diagnosed by exome sequencing and a literature review.
Song A, Im M, Kim MS, et al.
Annals of pediatric endocrinology & metabolism 2023; (28(1)):67-72 doi:10.6065/apem.2142134.067.
PMID: 35038833 - 2
Foramen magnum compression in Coffin-Lowry syndrome: A case report.
Upadia J, Oakes J, Hamm A, et al.
American journal of medical genetics. Part A 2017; (173(4)):1087-1089 doi:10.1002/ajmg.a.38095.
PMID: 28190284 - 3
Genome-wide association analysis for lethal brachycephalic-like facial dysmorphia in Labrador Retrievers.
Vasiliadis D, Dierks C, Hoffmann H, et al.
Animal genetics 2020; (51(1)):122-126 doi:10.1111/age.12875.
PMID: 31691328 - 4
A familial case of Coffin-Lowry syndrome caused by RPS6KA3 C.898C>T mutation associated with multiple abnormal brain imaging findings.
Tos T, Alp MY, Aksoy A, et al.
Genetic counseling (Geneva, Switzerland) 2015; (26(1)):47-52.
PMID: 26043507 - 5
Coffin-Lowry syndrome in Chinese.
Fung JLF, Rethanavelu K, Luk HM, et al.
American journal of medical genetics. Part A 2019; (179(10)):2043-2048 doi:10.1002/ajmg.a.61323.
PMID: 31400053 - 6
Coffin-Lowry syndrome: a systematic review of RPS6KA3 confirmed cases and implications for diagnosis and counseling.
Maity S, Montion M, Boothe D, et al.
Frontiers in genetics 2025; (16()):1715229 doi:10.3389/fgene.2025.1715229.
PMID: 41589305 - 7
Short Bones, Renal Stones, and Diagnostic Moans: Hypercalcemia in a Girl Found to Have Coffin-Lowry Syndrome.
Tise CG, Matalon DR, Manning MA, et al.
Journal of investigative medicine high impact case reports 2022; (10()):23247096221101844 doi:10.1177/23247096221101844.
PMID: 35638718 - 8
The natural history of spinal deformity in patients with Coffin-Lowry syndrome.
Welborn M, Farrell S, Knott P, et al.
Journal of children's orthopaedics 2018; (12(1)):70-75 doi:10.1302/1863-2548.12.170101.
PMID: 29456757 - 9
[Coffin-Lowry syndrome: Case report in Mexico].
Pérez-Peña AK, Juárez-Melchor D, Hernández-Castañeda Y
Revista medica del Instituto Mexicano del Seguro Social 2026; (64(3)):e6738 doi:10.5281/zenodo.18715449.
PMID: 42096245 - 10
625 kb microduplication at Xp22.12 including RPS6KA3 in a child with mild intellectual disability.
Bertini V, Cambi F, Bruno R, et al.
Journal of human genetics 2015; (60(12)):777-80 doi:10.1038/jhg.2015.106.
PMID: 26354035
This guide to Coffin-Lowry Syndrome is for informational purposes only. Always consult your child's pediatrician, geneticist, and care team for medical advice and personalized care planning.
Get notified when new evidence is published on Coffin-Lowry syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.